Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 59

1.

Knowing More of the Iceberg: How Detecting a Greater Proportion of Carbapenem-Resistant Enterobacteriaceae (CRE) Carriers Impacts Transmission.

Bartsch SM, Wong KF, Stokes-Cawley OJ, McKinnell JA, Cao C, Gussin GM, Mueller LE, Kim DS, Miller LG, Huang SS, Lee BY.

J Infect Dis. 2019 May 31. pii: jiz288. doi: 10.1093/infdis/jiz288. [Epub ahead of print]

PMID:
31150539
2.

Postdischarge Infection Risk among MRSA Carriers. Reply.

Huang SS, McKinnell JA, Miller LG.

N Engl J Med. 2019 May 30;380(22):2182. doi: 10.1056/NEJMc1903763. No abstract available.

PMID:
31141648
3.

A Multidisciplinary Approach to Incorporate Bedside Nurses into Antimicrobial Stewardship and Infection Prevention.

Ha DR, Forte MB, Olans RD, OYong K, Olans RN, Gluckstein DP, Kullar R, Desai M, Catipon N, Ancheta V, Lira D, Khattak Y, Legge J, Nguyen KB, Chan S, Mourani J, McKinnell JA.

Jt Comm J Qual Patient Saf. 2019 Apr 24. pii: S1553-7250(18)30391-X. doi: 10.1016/j.jcjq.2019.03.003. [Epub ahead of print]

PMID:
31029590
4.

A Bayesian model of acquisition and clearance of bacterial colonization incorporating within-host variation.

Järvenpää M, Sater MRA, Lagoudas GK, Blainey PC, Miller LG, McKinnell JA, Huang SS, Grad YH, Marttinen P.

PLoS Comput Biol. 2019 Apr 22;15(4):e1006534. doi: 10.1371/journal.pcbi.1006534. eCollection 2019 Apr.

5.

Delafloxacin in Acute Bacterial Skin and Skin Structure Infections.

Corey GR, McKinnell JA, Rybak MJ.

Clin Infect Dis. 2019 Apr 8;68(Supplement_3):S191-S192. doi: 10.1093/cid/ciy1089. No abstract available.

6.

Tracking the spread of carbapenem-resistant Enterobacteriaceae (CRE) through clinical cultures alone underestimates the spread of CRE even more than anticipated.

Lee BY, Bartsch SM, Wong KF, Kim DS, Cao C, Mueller LE, Gussin GM, McKinnell JA, Miller LG, Huang SS.

Infect Control Hosp Epidemiol. 2019 Jun;40(6):731-734. doi: 10.1017/ice.2019.61. Epub 2019 Mar 28. No abstract available.

7.

Risk Factors for Development of Carbapenem Resistance Among Gram-Negative Rods.

Richter SE, Miller L, Needleman J, Uslan DZ, Bell D, Watson K, Humphries R, McKinnell JA.

Open Forum Infect Dis. 2019 Jan 23;6(3):ofz027. doi: 10.1093/ofid/ofz027. eCollection 2019 Mar.

8.

Plazomicin for Infections Caused by Carbapenem-Resistant Enterobacteriaceae.

McKinnell JA, Dwyer JP, Talbot GH, Connolly LE, Friedland I, Smith A, Jubb AM, Serio AW, Krause KM, Daikos GL; CARE Study Group.

N Engl J Med. 2019 Feb 21;380(8):791-793. doi: 10.1056/NEJMc1807634. No abstract available.

PMID:
30786196
9.

Decolonization to Reduce Postdischarge Infection Risk among MRSA Carriers.

Huang SS, Singh R, McKinnell JA, Park S, Gombosev A, Eells SJ, Gillen DL, Kim D, Rashid S, Macias-Gil R, Bolaris MA, Tjoa T, Cao C, Hong SS, Lequieu J, Cui E, Chang J, He J, Evans K, Peterson E, Simpson G, Robinson P, Choi C, Bailey CC Jr, Leo JD, Amin A, Goldmann D, Jernigan JA, Platt R, Septimus E, Weinstein RA, Hayden MK, Miller LG; Project CLEAR Trial.

N Engl J Med. 2019 Feb 14;380(7):638-650. doi: 10.1056/NEJMoa1716771.

PMID:
30763195
10.

The SHIELD Orange County Project -Multi Drug-Resistant Organism (MDRO) Prevalence in 21 Nursing Homes and Long Term Acute Care Facilities in Southern California.

McKinnell JA, Singh RD, Miller LG, Kleinman K, Gussin G, He J, Saavedra R, Dutciuc TD, Estevez M, Chang J, Heim L, Yamaguchi S, Custodio H, Gohil SK, Park S, Tam S, Robinson PA, Tjoa T, Nguyen J, Evans KD, Bittencourt CE, Lee BY, Mueller LE, Bartsch SM, Jernigan JA, Slayton RB, Stone ND, Zahn M, Mor V, McConeghy K, Baier RR, Janssen L, O'Donnell K, Weinstein RA, Hayden MK, Coady MH, Bhattarai M, Peterson EM, Huang SS; CDC Safety and Healthcare Epidemiology Prevention Research Development (SHEPheRD) Program.

Clin Infect Dis. 2019 Feb 11. doi: 10.1093/cid/ciz119. [Epub ahead of print]

PMID:
30753383
11.

Clinical Outcomes of Infective Endocarditis in Injection Drug Users.

Rudasill SE, Sanaiha Y, Mardock AL, Khoury H, Xing H, Antonios JW, McKinnell JA, Benharash P.

J Am Coll Cardiol. 2019 Feb 12;73(5):559-570. doi: 10.1016/j.jacc.2018.10.082.

PMID:
30732709
12.

Public Health Efforts Can Impact Adoption of Current Susceptibility Breakpoints, but Closer Attention from Regulatory Bodies Is Needed.

McKinnell JA, Bhaurla S, Marquez-Sung P, Pucci A, Baron M, Kamali T, Bugante J, Schwartz B, Balter S, Terashita D, Butler-Wu S, Gunzenhauser J, Hindler J, Humphries RM.

J Clin Microbiol. 2019 Feb 27;57(3). pii: e01488-18. doi: 10.1128/JCM.01488-18. Print 2019 Mar.

PMID:
30567751
13.

Practical methods for effective vancomycin-resistant enterococci (VRE) surveillance: experience in a liver transplant surgical intensive care unit.

Linfield RY, Campeau S, Injean P, Gregson A, Kaldas F, Rubin Z, Kim T, Kunz D, Chan A, Lee DJ, Humphries RM, McKinnell JA.

Infect Control Hosp Epidemiol. 2018 Oct;39(10):1178-1182. doi: 10.1017/ice.2018.178. Epub 2018 Sep 4.

PMID:
30178725
14.

Risk Factors for Colistin Resistance among Gram-Negative Rods and Klebsiella pneumoniae Isolates.

Richter SE, Miller L, Uslan DZ, Bell D, Watson K, Humphries R, McKinnell JA.

J Clin Microbiol. 2018 Aug 27;56(9). pii: e00149-18. doi: 10.1128/JCM.00149-18. Print 2018 Sep.

15.

Bayesian evidence and epidemiological implications of environmental contamination from acute respiratory infection in long-term care facilities.

Diaz-Decaro JD, Launer B, Mckinnell JA, Singh R, Dutciuc TD, Green NM, Bolaris M, Huang SS, Miller LG.

Epidemiol Infect. 2018 May;146(7):832-838. doi: 10.1017/S0950268818000729. Epub 2018 Apr 10.

PMID:
29633685
16.

The Economic Value of the Centers for Disease Control and Prevention Carbapenem-Resistant Enterobacteriaceae Toolkit.

Bartsch SM, Huang SS, McKinnell JA, Wong KF, Mueller LE, Miller LG, Lee BY.

Infect Control Hosp Epidemiol. 2018 May;39(5):516-524. doi: 10.1017/ice.2018.49. Epub 2018 Mar 19.

17.

Effective Antimicrobial Stewardship Strategies for Cost-effective Utilization of Telavancin for the Treatment of Patients With Hospital-acquired Bacterial Pneumonia Caused by Staphylococcus aureus.

McKinnell JA, Corman S, Patel D, Leung GH, Gordon LM, Lodise TP.

Clin Ther. 2018 Mar;40(3):406-414.e2. doi: 10.1016/j.clinthera.2018.01.010. Epub 2018 Feb 15.

18.

Carbapenem-Resistant Enterobacteriaceae Detection Practices in California: What Are We Missing?

Humphries RM, Hindler JA, Epson E, Horwich-Scholefield S, Miller LG, Mendez J, Martinez JB, Sinkowitz J, Sinkowtiz D, Hershey C, Marquez P, Bhaurla S, Moran M, Pandes L, Terashita D, McKinnell JA.

Clin Infect Dis. 2018 Mar 19;66(7):1061-1067. doi: 10.1093/cid/cix942.

PMID:
29099915
19.

Secular Trends in Nosocomial Vancomycin-Resistant Enterococcal Bloodstream Infections Among United States Veterans Affairs Hospitals, Fiscal Years 2004 through 2014.

Britt NS, Potter EM, McKinnell JA, Patel N, Battersby SE, Steed ME.

Infect Control Hosp Epidemiol. 2017 Sep;38(9):1114-1116. doi: 10.1017/ice.2017.125. Epub 2017 Jul 11. No abstract available.

PMID:
28693646
20.

Discontinuation of contact precautions with the introduction of universal daily chlorhexidine bathing.

McKinnell JA, Eells SJ, Clark E, Rand DD, Kiet GT, Macias-Gil R, Mendez JM, Huang SS, Milefchik EN, Miller LG.

Epidemiol Infect. 2017 Sep;145(12):2575-2581. doi: 10.1017/S0950268817001121. Epub 2017 Jun 9.

21.

A Systematic Review and Meta-Analysis of the Data Behind Current Recommendations for Corticosteroids in Non-HIV-Related PCP: Knowing When You Are on Shaky Foundations.

Injean P, Eells SJ, Wu H, McElroy I, Gregson AL, McKinnell JA.

Transplant Direct. 2017 Feb 15;3(3):e137. doi: 10.1097/TXD.0000000000000642. eCollection 2017 Mar.

22.

Potential economic burden of carbapenem-resistant Enterobacteriaceae (CRE) in the United States.

Bartsch SM, McKinnell JA, Mueller LE, Miller LG, Gohil SK, Huang SS, Lee BY.

Clin Microbiol Infect. 2017 Jan;23(1):48.e9-48.e16. doi: 10.1016/j.cmi.2016.09.003. Epub 2016 Sep 15.

23.

Prevalence of and Factors Associated With Multidrug Resistant Organism (MDRO) Colonization in 3 Nursing Homes.

McKinnell JA, Miller LG, Singh R, Kleinman K, Peterson EM, Evans KD, Dutciuc TD, Heim L, Gombosev A, Estevez M, Launer B, Tjoa T, Tam S, Bolaris MA, Huang SS.

Infect Control Hosp Epidemiol. 2016 Dec;37(12):1485-1488. Epub 2016 Sep 27.

PMID:
27671022
24.

Impact of Delays between Clinical and Laboratory Standards Institute and Food and Drug Administration Revisions of Interpretive Criteria for Carbapenem-Resistant Enterobacteriaceae.

Bartsch SM, Huang SS, Wong KF, Slayton RB, McKinnell JA, Sahm DF, Kazmierczak K, Mueller LE, Jernigan JA, Lee BY.

J Clin Microbiol. 2016 Nov;54(11):2757-2762. Epub 2016 Aug 31.

25.

Impact of an Institutional Antimicrobial Stewardship Program on Bacteriology of Surgical Site Infections in Cardiac Surgery.

Ashfaq A, Zhu A, Iyengar A, Wu H, Humphries R, McKinnell JA, Shemin R, Benharash P.

J Card Surg. 2016 Jun;31(6):367-72. doi: 10.1111/jocs.12756. Epub 2016 May 5.

PMID:
27151622
26.

Patient-level analysis of incident vancomycin-resistant enterococci colonization and antibiotic days of therapy.

McKINNELL JA, Kunz DF, Moser SA, Vangala S, Tseng CH, Shapiro M, Miller LG.

Epidemiol Infect. 2016 Jun;144(8):1748-55. doi: 10.1017/S0950268815003118.

27.

Beyond the Intensive Care Unit (ICU): Countywide Impact of Universal ICU Staphylococcus aureus Decolonization.

Lee BY, Bartsch SM, Wong KF, McKinnell JA, Cui E, Cao C, Kim DS, Miller LG, Huang SS.

Am J Epidemiol. 2016 Mar 1;183(5):480-9. doi: 10.1093/aje/kww008. Epub 2016 Feb 11.

28.

The Potential Trajectory of Carbapenem-Resistant Enterobacteriaceae, an Emerging Threat to Health-Care Facilities, and the Impact of the Centers for Disease Control and Prevention Toolkit.

Lee BY, Bartsch SM, Wong KF, McKinnell JA, Slayton RB, Miller LG, Cao C, Kim DS, Kallen AJ, Jernigan JA, Huang SS.

Am J Epidemiol. 2016 Mar 1;183(5):471-9. doi: 10.1093/aje/kwv299. Epub 2016 Feb 8.

29.

Correction for Humphries and McKinnell, Continuing Challenges for the Clinical Laboratory for Detection of Carbapenem-Resistant Enterobacteriaceae.

Humphries RM, McKinnell JA.

J Clin Microbiol. 2016 Feb;54(2):509. doi: 10.1128/JCM.03175-15. No abstract available.

30.

Comparative Effectiveness of Vancomycin Versus Daptomycin for MRSA Bacteremia With Vancomycin MIC >1 mg/L: A Multicenter Evaluation.

Moise PA, Culshaw DL, Wong-Beringer A, Bensman J, Lamp KC, Smith WJ, Bauer K, Goff DA, Adamson R, Leuthner K, Virata MD, McKinnell JA, Chaudhry SB, Eskandarian R, Lodise T, Reyes K, Zervos MJ.

Clin Ther. 2016 Jan 1;38(1):16-30. doi: 10.1016/j.clinthera.2015.09.017. Epub 2015 Nov 14.

PMID:
26585355
31.

Continuing Challenges for the Clinical Laboratory for Detection of Carbapenem-Resistant Enterobacteriaceae.

Humphries RM, McKinnell JA.

J Clin Microbiol. 2015 Dec;53(12):3712-4. doi: 10.1128/JCM.02668-15. Epub 2015 Oct 14. Erratum in: J Clin Microbiol. 2016 Feb;54(2):509.

32.

Vital Signs: Estimated Effects of a Coordinated Approach for Action to Reduce Antibiotic-Resistant Infections in Health Care Facilities - United States.

Slayton RB, Toth D, Lee BY, Tanner W, Bartsch SM, Khader K, Wong K, Brown K, McKinnell JA, Ray W, Miller LG, Rubin M, Kim DS, Adler F, Cao C, Avery L, Stone NT, Kallen A, Samore M, Huang SS, Fridkin S, Jernigan JA.

MMWR Morb Mortal Wkly Rep. 2015 Aug 7;64(30):826-31.

33.

Reply to O'Riordan et al.

McKinnell JA, Bartsch SM, Lee BY, Huang SS, Miller LG.

Infect Control Hosp Epidemiol. 2015 Jul;36(7):857-8. doi: 10.1017/ice.2015.112. No abstract available.

34.

Editorial Commentary: Linezolid vs Daptomycin for Vancomycin-Resistant Enterococci: The Evidence Gap Between Trials and Clinical Experience.

McKinnell JA, Arias CA.

Clin Infect Dis. 2015 Sep 15;61(6):879-82. doi: 10.1093/cid/civ449. Epub 2015 Jun 10. No abstract available.

35.

Clinical Outcomes of Daptomycin for Vancomycin-resistant Enterococcus Bacteremia.

Moise PA, Sakoulas G, McKinnell JA, Lamp KC, DePestel DD, Yoon MJ, Reyes K, Zervos MJ.

Clin Ther. 2015 Jul 1;37(7):1443-1453.e2. doi: 10.1016/j.clinthera.2015.04.008. Epub 2015 May 15.

PMID:
25982687
36.

Cost-benefit analysis from the hospital perspective of universal active screening followed by contact precautions for methicillin-resistant Staphylococcus aureus carriers.

McKinnell JA, Bartsch SM, Lee BY, Huang SS, Miller LG.

Infect Control Hosp Epidemiol. 2015 Jan;36(1):2-13. doi: 10.1017/ice.2014.1.

37.

Reply to Eschenauer et al.

Kullar R, McKinnell JA, Sakoulas G.

Clin Infect Dis. 2015 Feb 15;60(4):671-2. doi: 10.1093/cid/ciu885. Epub 2014 Nov 3. No abstract available.

39.

Variation in antibiotic prophylaxis selection for coronary artery bypass graft procedures in an era of increasing methicillin-resistant Staphylococcus aureus prevalence.

Hsiue PP, Gregson AL, Injean P, Vangala S, Brindis RG, Shemin RJ, Shahian DM, Miller LG, Shapiro MF, Benharash P, McKinnell JA.

Infect Control Hosp Epidemiol. 2014 Jun;35(6):737-40. doi: 10.1086/676436. Epub 2014 Apr 23. No abstract available.

40.

Survey of preoperative infection prevention for coronary artery bypass graft procedures.

Injean P, McKinnell JA, Hsiue PP, Vangala S, Miller LG, Benharash P, Brindis RG, Gregson AL.

Infect Control Hosp Epidemiol. 2014 Jun;35(6):736-7. doi: 10.1086/676435. Epub 2014 Apr 23. No abstract available.

41.

Adjunctive glucocorticoid therapy for non-HIV-related pneumocystis carinii pneumonia (NH-PCP).

McKinnell JA, Cannella AP, Injean P, Gregson A.

Am J Transplant. 2014 Apr;14(4):982-3. doi: 10.1111/ajt.12655. Epub 2014 Feb 19. No abstract available.

42.

Recurrent urinary tract infections among women: comparative effectiveness of 5 prevention and management strategies using a Markov chain Monte Carlo model.

Eells SJ, Bharadwa K, McKinnell JA, Miller LG.

Clin Infect Dis. 2014 Jan;58(2):147-60. doi: 10.1093/cid/cit646. Epub 2013 Sep 24.

43.

A systematic literature review and meta-analysis of factors associated with methicillin-resistant Staphylococcus aureus colonization at time of hospital or intensive care unit admission.

McKinnell JA, Miller LG, Eells SJ, Cui E, Huang SS.

Infect Control Hosp Epidemiol. 2013 Oct;34(10):1077-86. doi: 10.1086/673157. Epub 2013 Aug 19. Review.

44.

Systematic review and meta-analysis of linezolid and daptomycin for treatment of vancomycin-resistant enterococcal bloodstream infections.

Whang DW, Miller LG, Partain NM, McKinnell JA.

Antimicrob Agents Chemother. 2013 Oct;57(10):5013-8. doi: 10.1128/AAC.00714-13. Epub 2013 Jul 29. Review.

45.

Quantifying the impact of extranasal testing of body sites for methicillin-resistant Staphylococcus aureus colonization at the time of hospital or intensive care unit admission.

McKinnell JA, Huang SS, Eells SJ, Cui E, Miller LG.

Infect Control Hosp Epidemiol. 2013 Feb;34(2):161-70. doi: 10.1086/669095. Epub 2012 Dec 21. Review.

46.

A comparison of clinical outcomes between healthcare-associated infections due to community-associated methicillin-resistant Staphylococcus aureus strains and healthcare-associated methicillin-resistant S. aureus strains.

Eells SJ, McKinnell JA, Wang AA, Green NL, Whang D, O'Hara P, Brown ML, Miller LG.

Epidemiol Infect. 2013 Oct;141(10):2140-8. doi: 10.1017/S0950268812002634. Epub 2012 Dec 6.

47.

Association between vancomycin-resistant Enterococci bacteremia and ceftriaxone usage.

McKinnell JA, Kunz DF, Chamot E, Patel M, Shirley RM, Moser SA, Baddley JW, Pappas PG, Miller LG.

Infect Control Hosp Epidemiol. 2012 Jul;33(7):718-24. doi: 10.1086/666331. Epub 2012 May 14.

48.

Pneumocystis pneumonia in hospitalized patients: a detailed examination of symptoms, management, and outcomes in human immunodeficiency virus (HIV)-infected and HIV-uninfected persons.

McKinnell JA, Cannella AP, Kunz DF, Hook EW 3rd, Moser SA, Miller LG, Baddley JW, Pappas PG.

Transpl Infect Dis. 2012 Oct;14(5):510-8. doi: 10.1111/j.1399-3062.2012.00739.x. Epub 2012 May 1.

49.

In vitro endothelial cell damage is positively correlated with enhanced virulence and poor vancomycin responsiveness in experimental endocarditis due to methicillin-resistant Staphylococcus aureus.

Seidl K, Bayer AS, McKinnell JA, Ellison S, Filler SG, Xiong YQ.

Cell Microbiol. 2011 Oct;13(10):1530-41. doi: 10.1111/j.1462-5822.2011.01639.x. Epub 2011 Jul 21.

50.

Daily cranberry prophylaxis to prevent recurrent urinary tract infections may be beneficial in some populations of women.

Eells SJ, McKinnell JA, Miller LG.

Clin Infect Dis. 2011 Jun;52(11):1393-4; author reply 1394-5. doi: 10.1093/cid/cir190. No abstract available.

Supplemental Content

Loading ...
Support Center